|Bid||38.11 x 800|
|Ask||44.97 x 1100|
|Day's range||37.61 - 38.30|
|52-week range||28.03 - 48.50|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||54.00|
Orthofix's (OFIX) SpinalStim bone growth device demonstrates impressive fusion rates for patients recovering from lumbar fusion surgery.
LEWISVILLE, Texas, July 12, 2021--Publication of data evaluating lumbar fusion rates in patients treated adjunctively with the SpinalStim™ device show a 92.7-percent fusion rate.
Orthofix (OFIX) launches FORZA Ti PLIF Spacer System to improve posterior lumbar interbody fusion procedures in the United States.